// App-Quantinova.ai

[AB0371] : CLINICAL SIGNIFICANCE OF ANTI-ADALIMUMAB ANTIBODIES IN RHEUMATOID ARTHRITIS, ANKYLOSING SPONDILITIS AND PSORIASIC ARTHRITIS

Researchers

Presenter

  • A. Hoxha

Principal Investigators

  • A. Calligaro

  • M. Tonello

  • M. Favaro

  • V. Teghil

  • A. Ruffatti

  • L. Punzi

  • A. Carletto

  • G. Paolazzi

  • R. Bortolotti

  • M. Felicetti

  • R. Ramonda

  • T. Del Ross

  • C. Grava

  • M. Boaretto

Medical Centers

  • Department of Medicine, San Martino Hospital, Belluno, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Rheumatoid arthritis

  • Venous thrombosis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved